ANAB 241220 25.00C (ANAB241220C25000) Stock Options, News & Quotes

US OptionsDetailed Quotes

ANAB241220C25000

Watchlist

0.33
+0.28+560.00%

15min DelayClose Dec 20 15:59 ET

0.33High0.33Low

Intraday

5D
Daily

News

Truist Financial Maintains AnaptysBio(ANAB.US) With Hold Rating, Maintains Target Price $20
Moomoo NewsDec 20 13:31 ET · Ratings
J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating, Cuts Target Price to $36
Moomoo NewsDec 20 13:31 ET · Ratings
AnaptysBio Price Target Cut to $36.00/Share From $66.00 by JP Morgan
Dow JonesDec 19 12:15 ET · Ratings
AnaptysBio Is Maintained at Overweight by JP Morgan
Dow JonesDec 19 12:15 ET · Ratings
Truist Financial Maintains AnaptysBio(ANAB.US) With Hold Rating, Announces Target Price $20
Moomoo NewsDec 19 05:33 ET · Ratings
Truist Securities Cuts Price Target on AnaptysBio to $20 From $30, Maintains Hold Rating
MT NewswiresDec 18 10:10 ET · Ratings

Comments

Trytosaveabit

Dec 11 07:36

T1 news halt!

$AnaptysBio (ANAB.US)$ Reuters· 3 mins ago
AnaptysBio Inc - Anb032 Ad Trial and All Further Investment Will Be Discontinued

Jsmooth420365

Aug 31 22:56

$AnaptysBio (ANAB.US)$ looking good got smacked last timee it tested $40.. needs to break that on heavy volume 🤔

Jaguar8

May 9 15:54

$AnaptysBio (ANAB.US)$
NEWS
Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
Positive
Significant improvement in skin clearance for patients receiving imsidolimab in the Phase 3 trials
Excellent maintenance of skin clearance with no flares in patients on monthly maintenance dosing of imsidolimab
Positive safety and tolerability profile with no treatment-related serious adverse events reported
Low incidence ...

Jaguar8

May 9 15:53

$AnaptysBio (ANAB.US)$
NEWS
Anaptys To Receive $50 Mln In Capped Non-Recourse Monetization From Amended Agreement With Sagard In Exchange For Additional Jemperli Royalties

White_Shadow

May 1 10:43

$AnaptysBio (ANAB.US)$ Go baby go...